PDF

Shareholders Defeat MTD in Case Against Hospira, Inc.

February 13, 2013

Robbins Geller and its co-counsel successfully defeated, in large part, defendants' Motion to Dismiss securities case against Hospira, Inc. pending in Chicago federal court.

Attorneys

Practice Areas

Securities Fraud

Read More Firm News

“Landmark” $650 Million Settlement in Facebook Biometric Class Action Approved as a “Major Win” for Consumers in the Area of Digital Privacy
February 26, 2021
Robbins Geller Defeats Motion to Dismiss in COVID-19 Vaccine Securities Class Action
February 17, 2021
Robbins Geller’s Desiree Cummings Appointed to Plaintiffs’ Steering Committee in Blackbaud Data Breach MDL
February 17, 2021
Robbins Geller Recovers $87.5 Million for Southern Company Investors
February 8, 2021
Litigators of the Week: How Robbins Geller Landed a $1.2B Settlement in the Valeant Pharmaceuticals Securities Case
February 5, 2021

Main Menu